| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 8, 2024 | Nov 8, 2024 | Viking Therapeutics, Inc. | Director | Sell | 22.5 | -2,000 | -4.00% | ✗ | $137.3K |
| May 16, 2023 | May 18, 2023 | Viking Therapeutics, Inc. | Director | Sell | 7.5 | -16,000 | -25.01% | ✓ | $384K |
| Apr 24, 2023 | Apr 24, 2023 | Viking Therapeutics, Inc. | Director | Sell | 7.5 | -16,000 | -25.01% | ✓ | $352.1K |
| Apr 17, 2023 | Apr 18, 2023 | Viking Therapeutics, Inc. | Director | Sell | 7.5 | -20,786 | -30.23% | ✓ | $415.7K |
| May 29, 2018 | May 31, 2018 | Viking Therapeutics, Inc. | Director | Buy | 97.5 | +47,965 | 100.00% | ✗ | $250.3K |